ANTONAZZO, IPPAZIO COSIMO
ANTONAZZO, IPPAZIO COSIMO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system
2021 Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy
2021 Baldin E.; Zenesini C.; Antonazzo I.C.; Bartolomei I.; Caniatti L.; Costa M.; Curti E.; Ferraro D.; Foschi M.; Granella F.; Guareschi A.; Immovilli P.; Lugaresi A.; Malagu S.; Mancinelli L.; Montepietra S.; Mussuto V.; Neri W.; Pasquinelli M.; Pellegrino L.; Pesci I.; Poluzzi E.; Pugliatti M.; Ravasio A.; Riise T.; Salvi F.; Santangelo M.; Sireci F.; Sola P.; Strumia S.; Tsantes E.; Vignatelli L.; Vitetta F.; Viti B.; D'Alessandro R.
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems
2021 Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E.
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region
2021 Burato S.; Leonardi L.; Antonazzo I.C.; Raschi E.; Ajolfi C.; Baraghini M.; Chiarello A.; Delmonte V.; Di Castri L.; Donati M.; Fadda A.; Fedele D.; Ferretti A.; Gabrielli L.; Gobbi S.; Lughi S.; Mazzari M.; Pieraccini F.; Renzetti A.; Russi E.; Scanelli C.; Zanetti B.; Poluzzi E.
Diabetes is associated with decreased migraine risk: A nationwide cohort study
2018 Antonazzo, Ippazio Cosimo; Riise, Trond; Cortese, Marianna; Berge, Line Iden; Engeland, Anders; Bernt Fasmer, Ole; Lund, Anders; Joachim Ødegaard, Ketil; Poluzzi, Elisabetta; Bjornevik, Kjetil
Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice
2017 Canistro, D.; Vivarelli, F.; Ugolini, L.; Pinna, C.; Grandi, M.; Antonazzo, I.C.; Cirillo, S.; Sapone, A.; Cinti, S.; Lazzeri, L.; Conte, E.; Biagi, G
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System
2016 Raschi, Emanuel; Poluzzi, Elisabetta; Koci, Ariola; Antonazzo, IPPAZIO COSIMO; MARCHESINI REGGIANI, Giulio; DE PONTI, Fabrizio
Drug-induced Kounis syndrome: A matter of pharmacovigilance
2019 Raschi, Emanuel*; Fertonani Affini, Lorenzo; Antonazzo, Ippazio Cosimo; Diemberger, Igor; Poluzzi, Elisabetta; De Ponti, Fabrizio
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list?
2021 Raschi E.; Antonazzo I.C.; Poluzzi E.; De Ponti F.
Effect of Vitamin E supplementation on xenobiotic-metabolizing and antioxidant enzymes in rat
2014 Vivarelli, F.; Canistro, D.; Sapone, A.; Filippi, S.; Antonazzo, I. C.; BABOT MARQUILLAS, C.; Paolini, M.
Effetti del germoglio di Raphanus Sativus CV Sango in un modello animale di obesità
2015 Vivarelli, F.; Canistro, D.; Sapone, A.; BABOT MARQUILLAS, C.; DE NICOLA, G. R.; Iori, R.; Antonazzo, I. C.; Gentilini, F.; Paolini, M.
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis
2018 Mouchet, Julie; Salvo, Francesco; Raschi, Emanuel; Poluzzi, Elisabetta; Antonazzo, Ippazio Cosimo; De Ponti, Fabrizio; Bégaud, Bernard
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis
2018 Mouchet, Julie; Salvo, Francesco; Raschi, Emanuel; Poluzzi, Elisabetta; Antonazzo, Ippazio Cosimo; De Ponti, Fabrizio; Bégaud, Bernard
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System
2019 Ippazio Cosimo Antonazzo; Elisabetta Poluzzi; Emanuele Forcesi; Trond Riise; Kjetil Bjornevik; Elisa Baldin; Luigi Muratori; Fabrizio De Ponti; Emanuel Raschi
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres
2019 Berardi, Lorenzo; Antonazzo, Ippazio Cosimo; Piccinni, Carlo; Raschi, Emanuel; Forcesi, Emanuele; Fioritti, Angelo; Berardi, Domenico; De Ponti, Fabrizio; Piazza, Antonella; Poluzzi, Elisabetta*
LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS
2019 Lunghi, C; Antonazzo, IC; Poluzzi, E; Burato, S; Raschi, E; Forcesi, E; Sangiorgi, E; Menchetti, M; Roberge, P
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System
2018 Antonazzo, Ippazio Cosimo; Raschi, Emanuel; Forcesi, Emanuele; Riise, Trond; Bjornevik, Kjetil; Baldin, Elisa; De Ponti, Fabrizio; Poluzzi, Elisabetta
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system
2020 Antonazzo I.C.; Poluzzi E.; Forcesi E.; Salvo F.; Pariente A.; Marchesini G.; De Ponti F.; Raschi E.
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping
2017 Antonazzo, Ippazio Cosimo; Raschi, Emanuel; Vignatelli, Luca; Baldin, Elisa; Riise, Trond; Dâ alessandro, Roberto; De Ponti, Fabrizio; Poluzzi, Elisabetta
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study
2020 Lunghi C.; Antonazzo I.C.; Burato S.; Raschi E.; Zoffoli V.; Forcesi E.; Sangiorgi E.; Menchetti M.; Roberge P.; Poluzzi E.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system | Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi | 2021-01-01 | EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | - | 1.01 Articolo in rivista | adverse effect.pdf; Adverse events with sacubitrilvalsartan in the real world.pdf |
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy | Baldin E.; Zenesini C.; Antonazzo I.C.; Bartolomei I.; Caniatti L.; Costa M.; Curti E.; Ferraro D....; Foschi M.; Granella F.; Guareschi A.; Immovilli P.; Lugaresi A.; Malagu S.; Mancinelli L.; Montepietra S.; Mussuto V.; Neri W.; Pasquinelli M.; Pellegrino L.; Pesci I.; Poluzzi E.; Pugliatti M.; Ravasio A.; Riise T.; Salvi F.; Santangelo M.; Sireci F.; Sola P.; Strumia S.; Tsantes E.; Vignatelli L.; Vitetta F.; Viti B.; D'Alessandro R. | 2021-01-01 | NEUROEPIDEMIOLOGY | - | 1.01 Articolo in rivista | - |
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems | Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Ma...zzanti G.; De Ponti F.; Raschi E. | 2021-01-01 | CLINICAL NUTRITION | - | 1.01 Articolo in rivista | - |
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region | Burato S.; Leonardi L.; Antonazzo I.C.; Raschi E.; Ajolfi C.; Baraghini M.; Chiarello A.; Delmont...e V.; Di Castri L.; Donati M.; Fadda A.; Fedele D.; Ferretti A.; Gabrielli L.; Gobbi S.; Lughi S.; Mazzari M.; Pieraccini F.; Renzetti A.; Russi E.; Scanelli C.; Zanetti B.; Poluzzi E. | 2021-01-01 | FRONTIERS IN PHARMACOLOGY | - | 1.01 Articolo in rivista | burato.pdf; datasheet1.doc |
Diabetes is associated with decreased migraine risk: A nationwide cohort study | Antonazzo, Ippazio Cosimo; Riise, Trond; Cortese, Marianna; Berge, Line Iden; Engeland, Anders; B...ernt Fasmer, Ole; Lund, Anders; Joachim Ødegaard, Ketil; Poluzzi, Elisabetta; Bjornevik, Kjetil | 2018-01-01 | CEPHALALGIA | - | 1.01 Articolo in rivista | - |
Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice | Canistro, D.; Vivarelli, F.; Ugolini, L.; Pinna, C.; Grandi, M.; Antonazzo, I.C.; Cirillo, S.; Sa...pone, A.; Cinti, S.; Lazzeri, L.; Conte, E.; Biagi, G | 2017-01-01 | ITALIAN JOURNAL OF ANIMAL SCIENCE | - | 1.01 Articolo in rivista | 112 Canistro et al 2017 IJAS.pdf |
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System | Raschi, Emanuel; Poluzzi, Elisabetta; Koci, Ariola; Antonazzo, IPPAZIO COSIMO; MARCHESINI REGGIAN...I, Giulio; DE PONTI, Fabrizio | 2016-01-01 | NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | - | 1.01 Articolo in rivista | - |
Drug-induced Kounis syndrome: A matter of pharmacovigilance | Raschi, Emanuel*; Fertonani Affini, Lorenzo; Antonazzo, Ippazio Cosimo; Diemberger, Igor; Poluzzi..., Elisabetta; De Ponti, Fabrizio | 2019-01-01 | INTERNATIONAL JOURNAL OF CARDIOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list? | Raschi E.; Antonazzo I.C.; Poluzzi E.; De Ponti F. | 2021-01-01 | ANNALS OF THE RHEUMATIC DISEASES | - | 1.04 Replica / breve intervento (e simili) | - |
Effect of Vitamin E supplementation on xenobiotic-metabolizing and antioxidant enzymes in rat | Vivarelli, F.; Canistro, D.; Sapone, A.; Filippi, S.; Antonazzo, I. C.; BABOT MARQUILLAS, C.; Pao...lini, M. | 2014-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
Effetti del germoglio di Raphanus Sativus CV Sango in un modello animale di obesità | Vivarelli, F.; Canistro, D.; Sapone, A.; BABOT MARQUILLAS, C.; DE NICOLA, G. R.; Iori, R.; Antona...zzo, I. C.; Gentilini, F.; Paolini, M. | 2015-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis | Mouchet, Julie; Salvo, Francesco; Raschi, Emanuel; Poluzzi, Elisabetta; Antonazzo, Ippazio Cosimo...; De Ponti, Fabrizio; Bégaud, Bernard | 2018-01-01 | VACCINE | - | 1.01 Articolo in rivista | - |
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis | Mouchet, Julie; Salvo, Francesco; Raschi, Emanuel; Poluzzi, Elisabetta; Antonazzo, Ippazio Cosimo...; De Ponti, Fabrizio; Bégaud, Bernard | 2018-01-01 | PHARMACOLOGICAL RESEARCH | - | 1.01 Articolo in rivista | - |
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System | Ippazio Cosimo Antonazzo; Elisabetta Poluzzi; Emanuele Forcesi; Trond Riise; Kjetil Bjornevik; El...isa Baldin; Luigi Muratori; Fabrizio De Ponti; Emanuel Raschi | 2019-01-01 | MULTIPLE SCLEROSIS | - | 1.01 Articolo in rivista | - |
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres | Berardi, Lorenzo; Antonazzo, Ippazio Cosimo; Piccinni, Carlo; Raschi, Emanuel; Forcesi, Emanuele;... Fioritti, Angelo; Berardi, Domenico; De Ponti, Fabrizio; Piazza, Antonella; Poluzzi, Elisabetta* | 2019-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | journal.pone.0211938.pdf |
LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS | Lunghi, C; Antonazzo, IC; Poluzzi, E; Burato, S; Raschi, E; Forcesi, E; Sangiorgi, E; Menchetti, ...M; Roberge, P | 2019-01-01 | VALUE IN HEALTH | - | 1.06 Abstract in rivista | - |
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System | Antonazzo, Ippazio Cosimo; Raschi, Emanuel; Forcesi, Emanuele; Riise, Trond; Bjornevik, Kjetil; B...aldin, Elisa; De Ponti, Fabrizio; Poluzzi, Elisabetta | 2018-01-01 | EXPERT OPINION ON DRUG SAFETY | - | 1.01 Articolo in rivista | - |
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system | Antonazzo I.C.; Poluzzi E.; Forcesi E.; Salvo F.; Pariente A.; Marchesini G.; De Ponti F.; Raschi E. | 2020-01-01 | ACTA DIABETOLOGICA | - | 1.01 Articolo in rivista | - |
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping | Antonazzo, Ippazio Cosimo; Raschi, Emanuel; Vignatelli, Luca; Baldin, Elisa; Riise, Trond; Dâ al...essandro, Roberto; De Ponti, Fabrizio; Poluzzi, Elisabetta | 2017-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | - |
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study | Lunghi C.; Antonazzo I.C.; Burato S.; Raschi E.; Zoffoli V.; Forcesi E.; Sangiorgi E.; Menchetti ...M.; Roberge P.; Poluzzi E. | 2020-01-01 | NEUROPSYCHIATRIC DISEASE AND TREATMENT | - | 1.01 Articolo in rivista | lunghi et al. 2020.pdf |